Oligometastatic prostate cancer: time to integrate metastasis-directed therapy

Key Points

• Oligometastatic prostate cancer treatment shows promising outcomes when using metastasis-directed therapy, emphasizing its potential benefits.
• Patients treated with metastasis-directed therapy experienced significant improvements in cancer progression rates, particularly in early-stage cases.
• Observational analysis reveals that integrating metastasis-directed therapy into existing treatment protocols could enhance overall patient care.
• This highlights the need for further trials to validate these findings and explore long-term effects on patient survival.